Lotte Biologics
Seoul, South Korea lottebiologics.com From their website, Nov 2026
Work here? Claim this listing
About
LOTTE Biologics is a global contract development and manufacturing organization providing biologics and bioconjugate services across the full product lifecycle. It serves innovators developing programs from early development through commercial supply, with operations in the United States and South Korea.
Services
Antibody Development Services
End-to-end support from cell line development and process development to analytical validation and worldwide regulatory filings.
Bioconjugate Development Services
Integrated antibody manufacturing and bioconjugation support at a single US site.
Manufacturing Services
Flexible, scalable manufacturing support from early development through commercial supply.
CDMO: development & manufacturing
CMC & Quality Management
Integrated quality, analytical, and regulatory support from early development through commercial manufacturing.
Platform Technology
Proprietary technologies offered to support flexible, customized manufacturing solutions.
Cell Line Development
Cell line development support for biologics programs.
Cell line development
Process Development
Upstream and downstream process development and technology transfer support for multiple cell lines and biologic modalities.
Analytical Development
Analytical development support for development, validation, and characterization work.
5 more services
- Bioconjugate Manufacturing
- Bioconjugate Analytical Support
- Antibody Manufacturing
- Analytical Support
- Regulatory Support
- Turnaround
- 10 months from CLD to IND
Capabilities
- Assays and studies
- Process development
- Antibodies
- Analytical development
- CHO
- Toxicology
- Stability studies
9 more
- ADCs
- Analytical method development
- Analytical method validation
- Analytical method qualification
- Bioconjugate analytical development
- Bioconjugate characterization
- Stability testing
- Process characterization
- Method performance trending
- Scale and capacity
- 50L tox run
- 1.1 kL x4 bioreactors
- 5 kL x8 bioreactors
- 3 kL x8 bioreactors
- 15 kL x8 bioreactors
- Bioconjugate capacity up to 1000L single use
Instruments and platforms
- Ambr 250™
- TFF
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
- Recombinant protein
- Species and models
- CHO-S
- CHO-DG44
- CHO-K
- NS0
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CRDMO
- Quality
- Global quality framework (US and Korea operations) · inspection readiness · regulatory compliance
- Based in
- Seoul, South Korea
- Sites
- East Syracuse, NY, USA
- Incheon, Republic of Korea
- Songdo-dong, Yeonsu-gu, Incheon, Republic of Korea
- Serves
- United States, South Korea, worldwide
Public records
- FDA drug establishment registration
- 1317757 · ANALYSIS; API MANUFACTURE source